Sigilon Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.88
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.42
|
-0.27
|
0.15
|
35.71%
|
|
2022-06-30
|
-0.43
|
-0.44
|
-0.01
|
-2.33%
|
|
2022-03-31
|
-0.33
|
-0.43
|
-0.10
|
-30.30%
|
|
2021-12-31
|
-0.56
|
-0.55
|
0.01
|
1.79%
|
|
2021-09-30
|
-0.66
|
-0.63
|
0.03
|
4.55%
|
|
2021-06-30
|
-0.63
|
-0.65
|
-0.02
|
-3.17%
|
|
2021-03-31
|
-0.59
|
-0.60
|
-0.01
|
-1.69%
|
|
2020-12-31
|
-1.37
|
-1.15
|
0.22
|
16.06%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.14
|
|
2021-12-31
|
-2.43
|
|
2020-12-31
|
-5.05
|
|
2019-12-31
|
-10.70
|
|
2018-12-31
|
-2.53
|